ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 0642

COVID-19 Infection in Rheumatologic Patients on Treatment with Targeted Therapies
Abstract Number: 1280

COVID-19 Infections May Increase the Risk of SLE Flares
Abstract Number: PP12

COVID-19, Racism, and Gender Discrimination: The Function of Stress in Widening the Gap in Health Disparities
Abstract Number: 0051

COVID-Related Distress and Mental Health in Adult Rheumatology Patients During the COVID-19 Pandemic
Abstract Number: 0923

Criteria for the Diagnosis of Raynaud’s Phenomenon – Do They Recognize the Same Patients?
Abstract Number: 1230

Curcumin: Prevalence and Perceived Efficacy in the Treatment of Rheumatoid and Psoriatic Arthritis
Abstract Number: 1859

Curdlan-induced Villous Permeability, Luminal Pathobiont Translocation to the Ileal Crypts, Ileitis and Arthritis Are Mitigated by Clostridia in Colonised Germ-free SKG Mice
Abstract Number: 1700

Curricular Implementation of the Rheumatic Disease Patient Expert Program: The Students’ Perspective
Abstract Number: 1610

Cutaneous Side Effects of Hydroxychloroquine in Rheumatic Diseases –Combination of “Traditional” Multivariate Analysis for Risk Factors AndClassification Model Development Using Supervised Machine Learning –Single Centre Retrospective Cohort Study in India
Abstract Number: 0999

CXCL13 Is a Key Driver for Migration and Differentiation of Regulatory B Cells
Abstract Number: 0285

CXCL13 Neutralization Reduces Neuropsychiatric Manifestations in MRL/lpr Mice
Abstract Number: 0027

CYP2D6 Genotype and Reduced Codeine Analgesic Effect in Real-World Clinical Practice
Abstract Number: 0623

Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort
Abstract Number: 0449

Cytotoxic T Cells with a Chronic Antigen Exposure Phenotype Drive Immune Checkpoint Inhibitor Sicca
Abstract Number: 0312

Dactylitis Is Associated with Greater Disease Severity, Ultrasound Synovitis, and Erosive Damage, in Very Early DMARD Naïve Psoriatic Arthritis

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].